211
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Higher Concentration of Adrenocorticotropic Hormone Predicts Post-Stroke Depression

, , , , , , ORCID Icon, ORCID Icon, , , & show all
Pages 417-427 | Published online: 05 Apr 2022

References

  • Villa RF, Ferrari F, Moretti A. Post-stroke depression: mechanisms and pharmacological treatment. Pharmacol Ther. 2018;184:131–144. doi:10.1016/j.pharmthera.2017.11.005
  • Ayerbe L, Ayis S, Crichton S, Wolfe CD, Rudd AG. The long-term outcomes of depression up to 10 years after stroke; the South London stroke register. J Neurol Neurosurg Psychiatry. 2014;85(5):514–521. doi:10.1136/jnnp-2013-306448
  • Robinson RG, Jorge RE. Post-stroke depression: a review. Am J Psychiatry. 2016;173(3):221–231. doi:10.1176/appi.ajp.2015.15030363
  • Chun HY, Ford A, Kutlubaev MA, Almeida OP, Mead GE. Depression, anxiety, and suicide after stroke: a narrative review of the best available evidence. Stroke. 2021;53:1402–1410.
  • Zhang E, Liao P. Brain-derived neurotrophic factor and post-stroke depression. J Neurosci Res. 2020;98(3):537–548. doi:10.1002/jnr.24510
  • Taroza S, Rastenyte D, Burkauskas J, Podlipskyte A, Mickuviene N. Lower serum free triiodothyronine levels are associated with symptoms of depression after ischemic stroke. J Psychosom Res. 2019;122:29–35. doi:10.1016/j.jpsychores.2019.04.018
  • Loubinoux I, Kronenberg G, Endres M, et al. Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med. 2012;16(9):1961–1969. doi:10.1111/j.1582-4934.2012.01555.x
  • Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008;31(9):464–468. doi:10.1016/j.tins.2008.06.006
  • Joseph DN, Whirledge S. Stress and the HPA axis: balancing homeostasis and fertility. Int J Mol Sci. 2017;18(10):10. doi:10.3390/ijms18102224
  • Gaffey AE, Bergeman CS, Clark LA, Wirth MM. Aging and the HPA axis: stress and resilience in older adults. Neurosci Biobehav Rev. 2016;68:928–945. doi:10.1016/j.neubiorev.2016.05.036
  • Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci. 2004;29(3):185–193.
  • Sousa VC, Mantas I, Stroth N, et al. P11 deficiency increases stress reactivity along with HPA axis and autonomic hyperresponsiveness. Mol Psychiatry. 2021;26(7):3253–3265. doi:10.1038/s41380-020-00887-0
  • McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87(3):873–904. doi:10.1152/physrev.00041.2006
  • Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder-translating findings from humans to animal models and back. Frontiers in Psychiatry. 2020;10. doi:10.3389/fpsyt.2019.00974
  • Holsboer F, Ising M. Central CRH system in depression and anxiety - evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol. 2008;583(2–3):350–357. doi:10.1016/j.ejphar.2007.12.032
  • Keller J, Gomez R, Williams G, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatr. 2017;22(4):527–536. doi:10.1038/mp.2016.120
  • Belanoff JK, Kalehzan M, Sund B, Fleming Ficek SK, Schatzberg AF. Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry. 2001;158(10):1612–1616. doi:10.1176/appi.ajp.158.10.1612
  • Seth S, Lewis AJ, Galbally M. Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review. BMC Pregnancy Childbirth. 2016;16(1):124. doi:10.1186/s12884-016-0915-y
  • Dickens MJ, Pawluski JL. The HPA axis during the perinatal period: implications for perinatal depression. Endocrinology. 2018;159(11):3737–3746. doi:10.1210/en.2018-00677
  • Orta OR, Gelaye B, Bain PA, Williams MA. The association between maternal cortisol and depression during pregnancy, a systematic review. Arch Womens Ment Health. 2018;21(1):43–53. doi:10.1007/s00737-017-0777-y
  • Zorn JV, Schur RR, Boks MP, Kahn RS, Joels M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis. Psychoneuroendocrinology. 2017;77:25–36. doi:10.1016/j.psyneuen.2016.11.036
  • Hardeveld F, Spijker J, Vreeburg SA, et al. Increased cortisol awakening response was associated with time to recurrence of major depressive disorder. Psychoneuroendocrinology. 2014;50:62–71. doi:10.1016/j.psyneuen.2014.07.027
  • Ju Y, Wang M, Lu X, et al. The effects of childhood trauma on the onset, severity and improvement of depression: the role of dysfunctional attitudes and cortisol levels. J Affect Disord. 2020;276:402–410. doi:10.1016/j.jad.2020.07.023
  • Yue L, Xiao-Lin H, Tao S. The effects of chronic repetitive transcranial magnetic stimulation on glutamate and gamma-aminobutyric acid in rat brain. Brain Res. 2009;1260:94–99. doi:10.1016/j.brainres.2009.01.009
  • Sun W, Miao J, Song Y, et al. Systemic low-grade inflammation and depressive symptomology at chronic phase of ischemic stroke: the chain mediating role of fibrinogen and neutrophil counts. Brain Behav Immun. 2022;100:332–341. doi:10.1016/j.bbi.2021.10.011
  • Zheng YP, Zhao JP, Phillips M, et al. Validity and reliability of the Chinese Hamilton depression rating scale. Br J Psychiatry. 1988;152:660–664. doi:10.1192/bjp.152.5.660
  • Sun WZ, Li G, Song Y, et al. A web based dynamic MANA Nomogram for predicting the malignant cerebral edema in patients with large hemispheric infarction. BMC Neurol. 2020;20(1). doi:10.1186/s12883-020-01935-6
  • Huang G, Chen H, Wang Q, et al. High platelet-to-lymphocyte ratio are associated with post-stroke depression. J Affect Disord. 2019;246:105–111. doi:10.1016/j.jad.2018.12.012
  • Wang A, Xu J, Chen G, et al. Oxidized low-density lipoprotein predicts recurrent stroke in patients with minor stroke or TIA. Neurology. 2018;91(10):e947–e55. doi:10.1212/WNL.0000000000006118
  • Johannesen CDL, Langsted A, Mortensen MB, Nordestgaard BG. Association between low density lipoprotein and all cause and cause specific mortality in Denmark: prospective cohort study. BMJ Brit Med J. 2020;371:m4266.
  • Wang YY, Sun WZ, Miao JF, et al. Higher fasting C-peptide is associated with post-stroke depression: a multicenter prospective cohort study. BMC Neurol. 2021;21(1). doi:10.1186/s12883-021-02413-3
  • Ayerbe L, Ayis S, Wolfe CDA, Rudd AG. Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis. Brit J Psychiat. 2013;202(1):14–21. doi:10.1192/bjp.bp.111.107664
  • Pascoe MC, Parker AG. Physical activity and exercise as a universal depression prevention in young people: a narrative review. Early Interv Psychia. 2019;13(4):733–739. doi:10.1111/eip.12737
  • De Ryck A, Brouns R, Geurden M, Elseviers M, De Deyn PP, Engelborghs S. Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. J Geriatr Psych Neur. 2014;27(3):147–158. doi:10.1177/0891988714527514
  • Li G, Miao JF, Sun WH, et al. Lower serum uric acid is associated with post-stroke depression at discharge. Frontiers in Psychiatry. 2020;11:52.
  • Qiu XL, Miao JF, Lan Y, et al. Association of cerebral artery stenosis with post-stroke depression at discharge and 3 months after ischemic stroke onset. Frontiers in Psychiatry. 2020;11. doi:10.3389/fpsyt.2020.585201
  • Spalletta G, Cravello L, Imperiale F, et al. Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci. 2013;25(4):255–263. doi:10.1176/appi.neuropsych.12120399
  • Zhan HQ, Huang F, Yan FL, et al. Alterations in splenic function and gene expression in mice with depressive-like behavior induced by exposure to corticosterone. Int J Mol Med. 2017;39(2):327–336. doi:10.3892/ijmm.2017.2850
  • Wang H, Ahrens C, Rief W, Gantz S, Schiltenwolf M, Richter W. Influence of depression symptoms on serum tumor necrosis factor-alpha of patients with chronic low back pain. Arthritis Res Ther. 2010;12(5):R186. doi:10.1186/ar3156
  • Aizawa H, Cui WP, Tanaka K, Okamoto H. Hyperactivation of the habenula as a link between depression and sleep disturbance. Front Hum Neurosci. 2013;7. doi:10.3389/fnhum.2013.00826
  • Blair LM, Porter K, Leblebicioglu B, Christian LM. Poor sleep quality and associated inflammation predict preterm birth: heightened risk among African Americans. Sleep. 2015;38(8):1259–1267. doi:10.5665/sleep.4904
  • Bandyopadhyay A, Sigua NL. What is sleep deprivation? Am J Respir Crit Care Med. 2019;199(6):P11–P2. doi:10.1164/rccm.1996P11
  • Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234–256. doi:10.1016/j.neuron.2020.06.002
  • Adzic M, Djordjevic J, Djordjevic A, et al. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J Endocrinol. 2009;202(1):87–97. doi:10.1677/JOE-08-0509
  • Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1):55–89. doi:10.1210/edrv.21.1.0389
  • Pariante CM. Risk factors for development of depression and psychosis glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann N Y Acad Sci. 2009;1179:144–152.
  • Wei K, Xu YZ, Zhao ZX, et al. Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress. Int J Mol Med. 2016;38(1):337–344. doi:10.3892/ijmm.2016.2591
  • Guidotti G, Calabrese F, Anacker C, Racagni G, Pariante CM, Riva MA. Glucocorticoid receptor and FKBP5 expression is altered following exposure to chronic stress: modulation by antidepressant treatment. Neuropsychopharmacology. 2013;38(4):616–627. doi:10.1038/npp.2012.225
  • Djordjevic A, Adzic M, Djordjevic J, Radojcic MB. Stress type dependence of expression and cytoplasmic-nuclear partitioning of glucocorticoid receptor, Hsp90 and Hsp70 in Wistar rat brain. Neuropsychobiology. 2009;59(4):213–221. doi:10.1159/000223733
  • Pariante CM. Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol. 2017;27(6):554–559. doi:10.1016/j.euroneuro.2017.04.001
  • Ting EY, Yang AC, Tsai SJ. Role of interleukin-6 in depressive disorder. Int J Mol Sci. 2020;21(6):2194. doi:10.3390/ijms21062194
  • Carvalho LA, Juruena MF, Papadopoulos AS, et al. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology. 2008;33(13):3182–3189. doi:10.1038/npp.2008.44